160 related articles for article (PubMed ID: 21432552)
1. Economic analysis of use of counterfeit drugs: health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example.
Sugita M; Miyakawa M
Environ Health Prev Med; 2010 Jul; 15(4):244-51. PubMed ID: 21432552
[TBL] [Abstract][Full Text] [Related]
2. Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks.
Jackson G; Arver S; Banks I; Stecher VJ
Int J Clin Pract; 2010 Mar; 64(4):497-504. PubMed ID: 20088883
[TBL] [Abstract][Full Text] [Related]
3. [Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety].
Shofuda K; Aragane K; Igari Y; Matsumoto K; Ito K
Yakugaku Zasshi; 2014; 134(2):203-11. PubMed ID: 24492224
[TBL] [Abstract][Full Text] [Related]
4. The health and economic effects of counterfeit drugs.
Blackstone EA; Fuhr JP; Pociask S
Am Health Drug Benefits; 2014 Jun; 7(4):216-24. PubMed ID: 25126373
[TBL] [Abstract][Full Text] [Related]
5. Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction.
Yafi FA; Sharlip ID; Becher EF
Sex Med Rev; 2018 Apr; 6(2):242-252. PubMed ID: 28923561
[TBL] [Abstract][Full Text] [Related]
6. Profiling characteristics of men who use phosphodiesterase type 5 inhibitors based on obtaining patterns: data from the nationwide Japanese population.
Kimura M; Shimura S; Kobayashi H; Tai T; Chikano Y; Baba S; Kano M; Nagao K
J Sex Med; 2012 Jun; 9(6):1649-58. PubMed ID: 22513057
[TBL] [Abstract][Full Text] [Related]
7. [Counterfeit medicines--Japan and the world].
Sato D
Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
[TBL] [Abstract][Full Text] [Related]
8. Counterfeit analysis strategy illustrated by a case study.
Dégardin K; Roggo Y
Drug Test Anal; 2016; 8(3-4):388-97. PubMed ID: 26692552
[TBL] [Abstract][Full Text] [Related]
9. Internet-ordered viagra (sildenafil citrate) is rarely genuine.
Campbell N; Clark JP; Stecher VJ; Goldstein I
J Sex Med; 2012 Nov; 9(11):2943-51. PubMed ID: 22925379
[TBL] [Abstract][Full Text] [Related]
10. [Counterfeit phosphodiesterase type 5 inhibitors--growing safety risks for public health].
Fijałek Z; Sarna K; Błazewicz A; Marin J
Rocz Panstw Zakl Hig; 2010; 61(3):227-35. PubMed ID: 21365856
[TBL] [Abstract][Full Text] [Related]
11. Testing of complementarity of PDA and MS detectors using chromatographic fingerprinting of genuine and counterfeit samples containing sildenafil citrate.
Custers D; Krakowska B; De Beer JO; Courselle P; Daszykowski M; Apers S; Deconinck E
Anal Bioanal Chem; 2016 Feb; 408(6):1643-56. PubMed ID: 26753972
[TBL] [Abstract][Full Text] [Related]
12. Chemometrics and chromatographic fingerprints to discriminate and classify counterfeit medicines containing PDE-5 inhibitors.
Deconinck E; Sacré PY; Courselle P; De Beer JO
Talanta; 2012 Oct; 100():123-33. PubMed ID: 23141319
[TBL] [Abstract][Full Text] [Related]
13. Packaging analysis of counterfeit medicines.
Dégardin K; Guillemain A; Klespe P; Hindelang F; Zurbach R; Roggo Y
Forensic Sci Int; 2018 Oct; 291():144-157. PubMed ID: 30205292
[TBL] [Abstract][Full Text] [Related]
14. Characteristics, behaviors, and attitudes of men bypassing the healthcare system when obtaining phosphodiesterase type 5 inhibitors.
Schnetzler G; Banks I; Kirby M; Zou KH; Symonds T
J Sex Med; 2010 Mar; 7(3):1237-46. PubMed ID: 20136707
[TBL] [Abstract][Full Text] [Related]
15. Counterfeit drugs and medical devices in developing countries.
Glass BD
Res Rep Trop Med; 2014; 5():11-22. PubMed ID: 32669888
[TBL] [Abstract][Full Text] [Related]
16. [Chemical Analysis of Counterfeit Hepatitis C Drug Found in Japan].
Uchiyama N; Kamakura H; Masada S; Tsujimoto T; Hosoe J; Tokumoto H; Maruyama T; Goda Y; Hakamatsuka T
Yakugaku Zasshi; 2017 Oct; 137(10):1265-1276. PubMed ID: 28724837
[TBL] [Abstract][Full Text] [Related]
17. [Counterfeit drugs as a gobal threat to health].
Golocorbin Kon S; Mikov M
Med Pregl; 2011; 64(5-6):285-90. PubMed ID: 21789919
[TBL] [Abstract][Full Text] [Related]
18. Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment.
Mackey TK; Liang BA; York P; Kubic T
Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):59-67. PubMed ID: 25897059
[TBL] [Abstract][Full Text] [Related]
19. The dangers of sexual enhancement supplements and counterfeit drugs to "treat" erectile dysfunction.
Chiang J; Yafi FA; Dorsey PJ; Hellstrom WJ
Transl Androl Urol; 2017 Feb; 6(1):12-19. PubMed ID: 28217446
[TBL] [Abstract][Full Text] [Related]
20. Headspace-gas chromatographic fingerprints to discriminate and classify counterfeit medicines.
Custers D; Canfyn M; Courselle P; De Beer JO; Apers S; Deconinck E
Talanta; 2014 Jun; 123():78-88. PubMed ID: 24725867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
